Cargando…

Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer

BACKGROUND: To evaluate the prognostic value of E-cadherin, CD44, and MSH2 expression for colorectal cancer (CRC) and construct nomograms that can predict prognosis. METHODS: We retrospectively analyzed the expression of E-cadherin, CD44, and MSH2 in 223 paraffin-embedded stage II and III CRC specim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Jinmiao, Jiang, Yuming, Liu, Hao, Deng, Haijun, Yu, Jiang, Qi, Xiaolong, Ge, Weiting, Li, Guoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257192/ https://www.ncbi.nlm.nih.gov/pubmed/28126685 http://dx.doi.org/10.1016/j.tranon.2016.12.005

Ejemplares similares

Prognostic significance of E-Cadherin and CD44 expression in tumor tissue of colorectal carcinoma
por: Knezevic, T, et al.
Publicado: (2015)

Association Between the Immunohistochemistry Expression of E-cadherin, Beta-Catenin, and CD44 in Colorectal Adenocarcinoma
por: Tunuguntla, Amrutha, et al.
Publicado: (2023)

Clinical significance of MLH1/MSH2 for stage II/III sporadic colorectal cancer
por: Wang, Shui-Ming, et al.
Publicado: (2019)

Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
por: Creţu, Oana Iulia, et al.
Publicado: (2022)

Prognostic value and nomograms of proximal margin distance in gastric cancer with radical distal gastrectomy
por: Luo, Jun, et al.
Publicado: (2020)

The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers
por: Lawes, D A, et al.
Publicado: (2005)

The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
por: Wang, Zhenpeng, et al.
Publicado: (2019)

CD44 Upregulation in E-Cadherin-Negative Esophageal Cancers Results in Cell Invasion
por: Le Bras, Grégoire F., et al.
Publicado: (2011)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors
por: Palassin, Pascale, et al.
Publicado: (2021)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

The Tendency of Having MSH2 and MSH6 Microsatellite Instability among Clinicopathological Features in Patients with Colorectal Cancer
por: Arshita, Neni, et al.
Publicado: (2018)

Somatic Hypermutation in Muts Homologue (Msh)3-, Msh6-, and Msh3/Msh6-Deficient Mice Reveals a Role for the Msh2–Msh6 Heterodimer in Modulating the Base Substitution Pattern
por: Wiesendanger, Margrit, et al.
Publicado: (2000)

The Expression and Functional Significance of Vascular Endothelial-Cadherin, CD44, and Vimentin in Oral Squamous Cell Carcinoma
por: Irani, Soussan, et al.
Publicado: (2018)

Expression of cytotoxic T lymphocyte-associated antigen 4, CD44, and E-cadherin in the microenvironment of breast carcinomas
por: Savli, Tugce Bolme, et al.
Publicado: (2023)

Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients
por: Petersen, Sanne M, et al.
Publicado: (2013)

Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients
por: Rashid, Muhammad Usman, et al.
Publicado: (2019)

Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer
por: Sninsky, Jared A., et al.
Publicado: (2021)

Loss or Somatic Mutations of hMSH2 Occur in Hereditary Nonpolyposis Colorectal Cancers with hMSH2 Germline Mutations
por: Lu, Shi‐Long, et al.
Publicado: (1996)

Cytoplasmic MSH2 Related to Genomic Deletions in the MSH2/EPCAM Genes in Colorectal Cancer Patients With Suspected Lynch Syndrome
por: Dong, Lin, et al.
Publicado: (2021)

Prerecognition Diffusion Mechanism of Human DNA Mismatch Repair Proteins along DNA: Msh2-Msh3 versus Msh2-Msh6
por: Pal, Arumay, et al.
Publicado: (2020)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

Quantitative Immunohistochemical Analyses of the Expression of E-Cadherin, Thrombomodulin, CD44H and CD44v6 in Primary Tumours of pharynx/larynx Squamous Cell Carcinoma and their Lymph Node Metastases
por: Gaspar, Rocío Hernández, et al.
Publicado: (1999)

Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
por: Schneider, Nayê Balzan, et al.
Publicado: (2018)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

CD44v6 engages in colorectal cancer progression
por: Ma, Lixin, et al.
Publicado: (2019)

Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
por: Khelwatty, Said Abdullah, et al.
Publicado: (2019)

The prognostic value of CD44 isoform expression in endometrial cancer.
por: Tempfer, C., et al.
Publicado: (1998)

Predictive Value of CD44 for Prognosis in Patients with Breast Cancer
por: Roosta, Yousef, et al.
Publicado: (2020)

Digenic inheritance of MSH6 and MUTYH variants in familial colorectal cancer
por: Schubert, Stephanie A., et al.
Publicado: (2020)

Expression of CD133, E-cadherin and WWOX in colorectal cancer and related analysis
por: Sun, Wenwen, et al.
Publicado: (2017)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study
por: Ismael, Nour El Hoda S., et al.
Publicado: (2017)

MSH6 syndrome
por: Suchy, Janina, et al.
Publicado: (2008)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

Differential expression of Oct-4, CD44, and E-cadherin in eutopic and ectopic endometrium in ovarian endometriomas and their correlations with clinicopathological variables
por: Sancakli Usta, Ceyda, et al.
Publicado: (2020)

Prognostic Significance of CSN2, CD8, and MMR Status-Associated Nomograms in Patients with Colorectal Cancer
por: Zhu, Bing, et al.
Publicado: (2018)

Radiomics Nomogram for Prediction of Peritoneal Metastasis in Patients With Gastric Cancer
por: Huang, Weicai, et al.
Publicado: (2020)

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
por: Ozawa, M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_169dfk8hqipnflisn8bgsvvc3e